Skip to main content
Erschienen in: Journal of Neuro-Oncology 1/2011

01.08.2011 | Case Report

A complex karyotype in an atypical teratoid/rhabdoid tumor: case report and review of the literature

verfasst von: Mariela C. Coccé, Fabiana Lubieniecki, Uwe Kordes, Daniel Alderete, Marta S. Gallego

Erschienen in: Journal of Neuro-Oncology | Ausgabe 1/2011

Einloggen, um Zugang zu erhalten

Abstract

Atypical teratoid/rhabdoid tumor (AT/RT) is a highly aggressive and uncommon neoplasm of the central nervous system that usually occurs in children less than 2 years of age. It is characterized by deletions and/or mutations of the INI1 tumor suppressor gene located in chromosome band 22q11.2. We performed cytogenetic and molecular studies of an AT/RT on a 15-month-old boy. The tumor showed a complex karyotype with one cell line showing monosomy 22 and another near-tetraploid one with additional chromosomal abnormalities, involving chromosomes 2, 3, 5, 6, and Y, which had not been previously described. Sequence analysis of the tumor did not identify mutations of the INI1 gene. The karyotypic evolution observed in this tumor suggests that INI1 has an epigenetic role in the maintenance of genome integrity by affecting genes, which produces mitotic defects and polyploidy. Finally, this case is the first to support the theory that loss of INI1 could induce the chromosomal instability that might be responsible for the genesis of this tumor.
Literatur
1.
Zurück zum Zitat Rorke LB, Packer RJ, Biegel JA (1996) Central nervous system atypical teratoid/rhabdoid tumors of infancy and childhood: definition of an entity. J Neurosurg 85:56–65PubMedCrossRef Rorke LB, Packer RJ, Biegel JA (1996) Central nervous system atypical teratoid/rhabdoid tumors of infancy and childhood: definition of an entity. J Neurosurg 85:56–65PubMedCrossRef
2.
Zurück zum Zitat Zarovnaya EL, Pallatroni HF, Hug EB, Ball PA, Cromwell LD, Pipas JM, Fadul CE, Meyer LP, Park JP, Biegel JA, Perry A, Rhodes CH (2007) Atypical teratoid/rhabdoid tumor of the spine in an adult: case report and review of the literature. J Neurooncol 84:49–55PubMedCrossRef Zarovnaya EL, Pallatroni HF, Hug EB, Ball PA, Cromwell LD, Pipas JM, Fadul CE, Meyer LP, Park JP, Biegel JA, Perry A, Rhodes CH (2007) Atypical teratoid/rhabdoid tumor of the spine in an adult: case report and review of the literature. J Neurooncol 84:49–55PubMedCrossRef
3.
Zurück zum Zitat Versteege I, Sevenet N, Lange J, Rousseau-Merck M-F, Ambros P, Handgretinger R, Aurias A, Delattre O (1998) Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer. Nature 394:203–207PubMedCrossRef Versteege I, Sevenet N, Lange J, Rousseau-Merck M-F, Ambros P, Handgretinger R, Aurias A, Delattre O (1998) Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer. Nature 394:203–207PubMedCrossRef
4.
Zurück zum Zitat Biegel JA, Tan L, Zhang F, Wainwright L, Russo P, Rorke LB (2002) Alterations of the hSNF5/INI1 gene in central nervous system atypical teratoid/rhabdoid tumors and renal and extrarenal rhabdoid tumors. Clin Cancer Res 8:3461–3467PubMed Biegel JA, Tan L, Zhang F, Wainwright L, Russo P, Rorke LB (2002) Alterations of the hSNF5/INI1 gene in central nervous system atypical teratoid/rhabdoid tumors and renal and extrarenal rhabdoid tumors. Clin Cancer Res 8:3461–3467PubMed
5.
Zurück zum Zitat Judkins AR, Mauger J, Ht A, Rorke LB, Biegel JA (2004) Immunohistochemical analysis of hSNF5/INI1 in pediatric CNS neoplasms. Am J Surg Pathol 28:644–650PubMedCrossRef Judkins AR, Mauger J, Ht A, Rorke LB, Biegel JA (2004) Immunohistochemical analysis of hSNF5/INI1 in pediatric CNS neoplasms. Am J Surg Pathol 28:644–650PubMedCrossRef
6.
Zurück zum Zitat Schneppenheim R, Frühwald MC, Gesk S, Hasselblatt M, Jeibmann A, Kordes U, Kreuz M, Leuschner I, Martin Subero JI, Obser T, Oyen F, Vater I, Siebert R (2010) Germline nonsense mutation and somatic inactivation of SMARCA4/BRG1 in a family with rhabdoid tumor predisposition syndrome. Am J Hum Genet 86:279–284PubMedCrossRef Schneppenheim R, Frühwald MC, Gesk S, Hasselblatt M, Jeibmann A, Kordes U, Kreuz M, Leuschner I, Martin Subero JI, Obser T, Oyen F, Vater I, Siebert R (2010) Germline nonsense mutation and somatic inactivation of SMARCA4/BRG1 in a family with rhabdoid tumor predisposition syndrome. Am J Hum Genet 86:279–284PubMedCrossRef
7.
Zurück zum Zitat Shaffer LG, Slovak ML, Campbell LJ (2009) ISCN 2009: an international system for human cytogenetic nomenclature. S. Karger, Basel Shaffer LG, Slovak ML, Campbell LJ (2009) ISCN 2009: an international system for human cytogenetic nomenclature. S. Karger, Basel
8.
Zurück zum Zitat Biegel JA, Zhou JY, Rorke LB, Stenstrom C, Wainwright LM, Fogelgren B (1999) Germ-line and acquired mutations of INI1 in atypical teratoid and rhabdoid tumors. Cancer Res 59:74–79PubMed Biegel JA, Zhou JY, Rorke LB, Stenstrom C, Wainwright LM, Fogelgren B (1999) Germ-line and acquired mutations of INI1 in atypical teratoid and rhabdoid tumors. Cancer Res 59:74–79PubMed
9.
Zurück zum Zitat Jackson EM, Sievert AJ, Gai X, Hakonarson H, Judkins AR, Tooke L, Perin JC, Xie H, Shaikh TH, Biegel JA (2009) Genomic analysis using high-density single nucleotide polymorphism-based oligonucleotide arrays and multiplex ligation-dependent probe amplification provides a comprehensive analysis of INI1/SMARCB1 in malignant rhabdoid tumors. Clin Cancer Res 15:1923–1930PubMedCrossRef Jackson EM, Sievert AJ, Gai X, Hakonarson H, Judkins AR, Tooke L, Perin JC, Xie H, Shaikh TH, Biegel JA (2009) Genomic analysis using high-density single nucleotide polymorphism-based oligonucleotide arrays and multiplex ligation-dependent probe amplification provides a comprehensive analysis of INI1/SMARCB1 in malignant rhabdoid tumors. Clin Cancer Res 15:1923–1930PubMedCrossRef
10.
Zurück zum Zitat Bhattacharjee MB, Armstrong DD, Vogel H, Cooley LD (1997) Cytogenetic analysis of 120 primary pediatric brain tumors and literature review. Cancer Genet Cytogenet 97:39–53PubMedCrossRef Bhattacharjee MB, Armstrong DD, Vogel H, Cooley LD (1997) Cytogenetic analysis of 120 primary pediatric brain tumors and literature review. Cancer Genet Cytogenet 97:39–53PubMedCrossRef
11.
Zurück zum Zitat Proust F, Laquerriere A, Constantin B, Ruchoux MM, Vannier JP, Freger P (1999) Simultaneous presentation of atypical teratoid/rhabdoid tumor in siblings. J Neurooncol 43:63–70PubMedCrossRef Proust F, Laquerriere A, Constantin B, Ruchoux MM, Vannier JP, Freger P (1999) Simultaneous presentation of atypical teratoid/rhabdoid tumor in siblings. J Neurooncol 43:63–70PubMedCrossRef
12.
Zurück zum Zitat Biegel JA, Fogelgren B, Wainwright LM, Zhou JY, Bevan H, Rorke LB (2000) Germline INI1 mutation in a patient with a central nervous system atypical teratoid tumor and renal rhabdoid tumor. Genes Chromosom Cancer 28:31–37PubMedCrossRef Biegel JA, Fogelgren B, Wainwright LM, Zhou JY, Bevan H, Rorke LB (2000) Germline INI1 mutation in a patient with a central nervous system atypical teratoid tumor and renal rhabdoid tumor. Genes Chromosom Cancer 28:31–37PubMedCrossRef
13.
Zurück zum Zitat Biegel JA, Rorke LB, Packer RJ, Emanuel BS (1990) Monosomy 22 in rhabdoid or atypical teratoid tumors of the brain. J Neurosurg 73:710–714PubMedCrossRef Biegel JA, Rorke LB, Packer RJ, Emanuel BS (1990) Monosomy 22 in rhabdoid or atypical teratoid tumors of the brain. J Neurosurg 73:710–714PubMedCrossRef
14.
Zurück zum Zitat Hasserjian RP, Folkerth RD, Scott RM, Schofield DE (1995) Clinicopathologic and cytogenetic analysis of malignant rhabdoid tumor of the central nervous system. J Neurooncol 25:193–203PubMedCrossRef Hasserjian RP, Folkerth RD, Scott RM, Schofield DE (1995) Clinicopathologic and cytogenetic analysis of malignant rhabdoid tumor of the central nervous system. J Neurooncol 25:193–203PubMedCrossRef
15.
Zurück zum Zitat Muller M, Hubbard SL, Fukuyama K, Dirks P, Matsuzawa K, Rutka JT (1995) Characterization of a pineal region malignant rhabdoid tumor. Pediatr Neurosurg 22:204–209PubMedCrossRef Muller M, Hubbard SL, Fukuyama K, Dirks P, Matsuzawa K, Rutka JT (1995) Characterization of a pineal region malignant rhabdoid tumor. Pediatr Neurosurg 22:204–209PubMedCrossRef
16.
Zurück zum Zitat Douglass EC, Valentine M, Rowe ST, Parham DM, Wilimas JA, Sanders JM, Houghton PJ (1990) Malignant rhabdoid tumor: a highly malignant childhood tumor with minimal karyotypic changes. Genes Chromosom Cancer 2:210–216PubMedCrossRef Douglass EC, Valentine M, Rowe ST, Parham DM, Wilimas JA, Sanders JM, Houghton PJ (1990) Malignant rhabdoid tumor: a highly malignant childhood tumor with minimal karyotypic changes. Genes Chromosom Cancer 2:210–216PubMedCrossRef
17.
Zurück zum Zitat Biegel JA, Burk CD, Parmiter AH, Emanuel BS (1992) Molecular analysis of a partial deletion of 22q in a central nervous system rhabdoid tumor. Genes Chromosom Cancer 5:104–108PubMedCrossRef Biegel JA, Burk CD, Parmiter AH, Emanuel BS (1992) Molecular analysis of a partial deletion of 22q in a central nervous system rhabdoid tumor. Genes Chromosom Cancer 5:104–108PubMedCrossRef
18.
Zurück zum Zitat Agamanolis DP, Malone JM (1995) Chromosomal abnormalities in 47 pediatric brain tumors. Cancer Genet Cytogenet 81:125–134PubMedCrossRef Agamanolis DP, Malone JM (1995) Chromosomal abnormalities in 47 pediatric brain tumors. Cancer Genet Cytogenet 81:125–134PubMedCrossRef
19.
Zurück zum Zitat Klopfenstein K, Soukup S, Blough R, Mazewski C, Ballard E, Gotwals B, Lampkin B (1997) Chromosome analyses in a rhabdoid tumor of the brain. Cancer Genet Cytogenet 93:152–156PubMedCrossRef Klopfenstein K, Soukup S, Blough R, Mazewski C, Ballard E, Gotwals B, Lampkin B (1997) Chromosome analyses in a rhabdoid tumor of the brain. Cancer Genet Cytogenet 93:152–156PubMedCrossRef
20.
Zurück zum Zitat Sawyer JR, Goosen LS, Swanson CM, Tomita T, de Leon GA (1998) A new reciprocal translocation (12;22) (q24.3;q11.2–12) in a malignant rhabdoid tumor of the brain. Cancer Genet Cytogenet 101:62–67PubMedCrossRef Sawyer JR, Goosen LS, Swanson CM, Tomita T, de Leon GA (1998) A new reciprocal translocation (12;22) (q24.3;q11.2–12) in a malignant rhabdoid tumor of the brain. Cancer Genet Cytogenet 101:62–67PubMedCrossRef
21.
Zurück zum Zitat Karnes PS, Tran TN, Cui MY, Raffel C, Gilles FH, Barranger JA, Ying KL (1992) Cytogenetic analysis of 39 pediatric central nervous system tumors. Cancer Genet Cytogenet 59:12–19PubMedCrossRef Karnes PS, Tran TN, Cui MY, Raffel C, Gilles FH, Barranger JA, Ying KL (1992) Cytogenetic analysis of 39 pediatric central nervous system tumors. Cancer Genet Cytogenet 59:12–19PubMedCrossRef
22.
Zurück zum Zitat Lopez-Gines C, Cerda-Nicolas M, Kepes J, Donat J, Gil-Benso R, Llombart-Bosch A (2000) Complex rearrangement of chromosomes 6 and 11 as the sole anomaly in atypical teratoid/rhabdoid tumors of the central nervous system. Cancer Genet Cytogenet 122:149–152PubMedCrossRef Lopez-Gines C, Cerda-Nicolas M, Kepes J, Donat J, Gil-Benso R, Llombart-Bosch A (2000) Complex rearrangement of chromosomes 6 and 11 as the sole anomaly in atypical teratoid/rhabdoid tumors of the central nervous system. Cancer Genet Cytogenet 122:149–152PubMedCrossRef
23.
Zurück zum Zitat Wharton SB, Wardle C, Ironside JW, Wallace WH, Royds JA, Hammond DW (2003) Comparative genomic hybridization and pathological findings in atypical teratoid/rhabdoid tumour of the central nervous system. Neuropathol Appl Neurobiol 29:254–261PubMedCrossRef Wharton SB, Wardle C, Ironside JW, Wallace WH, Royds JA, Hammond DW (2003) Comparative genomic hybridization and pathological findings in atypical teratoid/rhabdoid tumour of the central nervous system. Neuropathol Appl Neurobiol 29:254–261PubMedCrossRef
24.
Zurück zum Zitat Rickert CH, Paulus W (2004) Chromosomal imbalances detected by comparative genomic hybridization in atypical teratoid/rhabdoid tumours. Childs Nerv Syst 20:221–224PubMedCrossRef Rickert CH, Paulus W (2004) Chromosomal imbalances detected by comparative genomic hybridization in atypical teratoid/rhabdoid tumours. Childs Nerv Syst 20:221–224PubMedCrossRef
25.
Zurück zum Zitat Vries RG, Bezrookove V, Zuijderduijn LM, Kia SK, Houweling A, Oruetxebarria I, Raap AK, Verrijzer CP (2005) Cancer-associated mutations in chromatin remodeler hSNF5 promote chromosomal instability by compromising the mitotic checkpoint. Genes Dev 19:665–670PubMedCrossRef Vries RG, Bezrookove V, Zuijderduijn LM, Kia SK, Houweling A, Oruetxebarria I, Raap AK, Verrijzer CP (2005) Cancer-associated mutations in chromatin remodeler hSNF5 promote chromosomal instability by compromising the mitotic checkpoint. Genes Dev 19:665–670PubMedCrossRef
26.
Zurück zum Zitat Hernando E, Nahlé Z, Juan G, Diaz-Rodriguez E, Alaminos M, Hemann M, Michel L, Mittal V, Gerald W, Benezra R, Lowe SW, Cordon-Cardo C (2004) Rb inactivation promotes genomic instability by uncoupling cell cycle progression from mitotic control. Nature 430:797–802PubMedCrossRef Hernando E, Nahlé Z, Juan G, Diaz-Rodriguez E, Alaminos M, Hemann M, Michel L, Mittal V, Gerald W, Benezra R, Lowe SW, Cordon-Cardo C (2004) Rb inactivation promotes genomic instability by uncoupling cell cycle progression from mitotic control. Nature 430:797–802PubMedCrossRef
27.
Zurück zum Zitat McKenna ES, Sansam CG, Cho YJ, Greulich H, Evans JA, Thom CS, Moreau LA, Biegel JA, Pomeroy SL, Roberts CWM (2008) Loss of the epigenetic tumor suppressor SNF5 leads to cancer without genomic instability. Mol Cell Biol 28:6223–6233PubMedCrossRef McKenna ES, Sansam CG, Cho YJ, Greulich H, Evans JA, Thom CS, Moreau LA, Biegel JA, Pomeroy SL, Roberts CWM (2008) Loss of the epigenetic tumor suppressor SNF5 leads to cancer without genomic instability. Mol Cell Biol 28:6223–6233PubMedCrossRef
Metadaten
Titel
A complex karyotype in an atypical teratoid/rhabdoid tumor: case report and review of the literature
verfasst von
Mariela C. Coccé
Fabiana Lubieniecki
Uwe Kordes
Daniel Alderete
Marta S. Gallego
Publikationsdatum
01.08.2011
Verlag
Springer US
Erschienen in
Journal of Neuro-Oncology / Ausgabe 1/2011
Print ISSN: 0167-594X
Elektronische ISSN: 1573-7373
DOI
https://doi.org/10.1007/s11060-010-0478-0

Weitere Artikel der Ausgabe 1/2011

Journal of Neuro-Oncology 1/2011 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 Demenz Nachrichten

Wenn Demenzkranke aufgrund von Symptomen wie Agitation oder Aggressivität mit Antipsychotika behandelt werden, sind damit offenbar noch mehr Risiken verbunden als bislang angenommen.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.